
Issue date: November 2010.
"This guidance updates and replaces recommendation 1.4 of TA86."
"The guidance was developed using the NICE multiple technology appraisal process."
Publisher's number: N2365.
Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours (part review of technology appraisal guidance 86) by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2010. Publication and catalogue information, links to buy online and reader comments.